CYTK EPS Estimates
Cytokinetics, Incorporated
$55.39
+$0.25(+0.45%)
40
Overall
40
Value
30
Tech
52
Quality
Market Cap
$7.72B
Volume
913.43K
52W Range
$53.55 - $88.31
Target Price
$107.14
CYTK EPS estimates: the consensus estimate for Cytokinetics, Incorporated's current fiscal year is -$5.86 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CYTK EPS Estimates
- EPS estimate, current quarter
- $-1.47
- EPS estimate, next quarter
- $-1.44
- EPS estimate, current year
- $-5.86
- EPS estimate, next year
- $-4.47
- EPS growth, 3-year
- -14.74%
| Fiscal year | EPS |
|---|---|
| 2025 | $-6.54 |
| 2024 | $-5.26 |
| 2023 | $-5.45 |
| 2022 | $-4.33 |
| 2021 | $-2.80 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $55.39 | +0.5% | 913.43K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics, Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW